Posting fresh info about MS, for people with MS and their supporters

  • Newly Published Data Show Copaxone Promoted Remyelination of Damaged Axons

    The purpose of this study was to examine the effect of glatiramer acetate on oligodendrogenesis (the formation of myelin-producing glial cells in the central nervous system) and [...]


    • Hot off the AAN Press: Tysabri Promotes Remyelination

      July 4, 2009 Biogen Idec (NASDAQ: BIIB) and Elan Corporation (NYSE: ELN) announced results of a study demonstrating that Tysabri® (natalizumab) promoted regeneration and stabilization of damage [...]


      • Put on Your Thinking Cap: Learning Increases Myelin

        Researchers at Oxford have proven that, when people learn a new skill (juggling), brain imaging shows that the white matter in their brain increased. This increase in [...]


Feeds

Search


SUPPORT / Find out More


 

TAG / CLOUD

aan, alemtuzumab, avonex, betaseron, biogen, bioms medical corp, campath, ccsvi, cis, cladribine, clarity, cognitive dysfunction, copaxone, daclizumab, dirucotide, discovery, ectrims, elan, fampridine-sr, fatigue, fda, fda fast track status, fingolimod, fty-720, genzyme, gilenia, gilenya, interferons, laquinimod, merck, merck/serono, novartis, oral ms therapies, phase iii, pml, rebif, rrms, serono, smoking, spms, stem cells, teriflunomide, teva, therapy, tysabri

ARCHIVES / PAST ARTICLES



Follow me on Twitter
Friend me on Facebook
Subscribe by Email




Bookmark and Share


Wordpress Engine. Upstart Theme. Better Project.